Advanced Biomed ADVB
NASDAQ ADVB
$6.32 +0.00 (+0.00%)
As of: Sep 30, 2026 · 10:09 AM EDT

Advanced Biomed (ADVB) Operating Leases (2024 - 2026)

Updated

Advanced Biomed's Operating Leases came in at $10,903 for fiscal Q3 2026 (quarter ended Mar 31, 2026), down 75.5% from $44,472 a year earlier but up 661.9% from the prior quarter.

Analysis

Advanced Biomed (ADVB) Operating Leases (2024 - 2026) Analysis & Trends

At the end of FY2025 (ended Jun 30, 2025), Advanced Biomed's Operating Leases was $5,879, down 90.9% from FY2024.

  • Going back by fiscal year, Operating Leases was $64,529 in FY2024.
  • The five-year range for quarterly Operating Leases is $1,431 (fiscal Q2 2026) to $64,529 (fiscal Q4 2024).
  • Business Quant data shows ADVB's Operating Leases at $1,431 (Q2 2026), $2,935 (Q1 2026) and $5,879 (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.84 Bn 229.99 Bn 4.88 Bn
2 Abbott Laboratories 174.73 Bn 145.82 Bn 7.27 Bn
3 Danaher 159.85 Bn 143.67 Bn 3.61 Bn
4 Intuitive Surgical 146.79 Bn 126.35 Bn 1.96 Bn
5 Medtronic 114.54 Bn 80.41 Bn 6.34 Bn
6 Stryker 105.67 Bn 91.79 Bn 4.50 Bn
7 Boston Scientific 63.93 Bn 58.94 Bn 3.85 Bn
8 Becton Dickinson 50.12 Bn 47.27 Bn 2.32 Bn
9 Edwards Lifesciences 50.06 Bn 34.17 Bn 1.35 Bn
10 Advanced Biomed 9.30 Mn 9.30 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 10,903.00
Dec 31, 2025 1,431.00
Sep 30, 2025 2,935.00
Jun 30, 2025 5,879.00
Mar 31, 2025 44,472.00
Dec 31, 2024 56,326.00
Jun 30, 2024 64,529.00
API Access

Advanced Biomed Operating Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-leases&ticker=ADVB&period=max&api_key=YOUR_API_KEY